Rhythm Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
RYTM Key Statistics
Stock Snapshot
Rhythm Pharmaceuticals(RYTM) stock is priced at $98.66, giving the company a market capitalization of 6.78B. It carries a P/E multiple of -31.64.
During the trading session on 2026-09-26, Rhythm Pharmaceuticals(RYTM) shares reached a daily high of $99.42 and a low of $96.35. At a current price of $98.66, the stock is +2.4% higher than the low and still -0.8% under the high.
Trading activity shows a volume of 861.14K, compared to an average daily volume of 777.29K.
Over the past 52 weeks, Rhythm Pharmaceuticals(RYTM) stock has traded between a high of $122.20 and a low of $74.50.
Over the past 52 weeks, Rhythm Pharmaceuticals(RYTM) stock has traded between a high of $122.20 and a low of $74.50.
RYTM News
Rhythm Pharmaceuticals reported that Health Canada previously approved IMCIVREE (setmelanotide) for weight management in adults and children 4 and older with ac...
Analyst ratings
89%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.